Anzeige
Anzeige

Más contenido relacionado

Anzeige
Anzeige

Swine Flu 2017

  1. CONTENT What is Swine flu? Symptoms of Swine flu? Mode of Transmission ? Period of Communicability? Incubation Period? Prevention of Swine flu TAKE HOME MESSAGE
  2. WHAT IS SWINE FLU? It is a respiratory disease caused by H1 N1 Type A Influenza Virus. It is like ordinary flu. The Swine flu was initially seen in humans in Mexico in 2009, where the strand of the particular virus was a marriage of 3 types of strands.
  3. WHAT IS SWINE FLU?
  4. WHAT IS SWINE FLU?
  5. WHAT IS SWINE FLU?  The major reason of its world wide spread is the lack of immunity against the virus in a large population. WHO declares swine flu as pandemic on 11 June 2009.
  6. SYMPTOMS OF SWINE FLU?
  7. SYMPTOMS OF SWINE FLU?  Fever  Sore Throat  Cough  Headache  Body ache  Lethargy  Diarrhoea and Vomiting
  8. Mode of Transmission?
  9. Mode of Transmission?  Cough and Sneezing by Infected Indl  Virus deposited on any Surface  Healthy indl touches the contaminated surface  Healthy Indl touches his Eyes, Nose or Mouth  Healthy Indl becomes infected
  10. Period of Communicability? 1 Day 7 Days
  11. Incubation Period? 2 Days (1-4 Days)
  12. High Risk Group  Children with mild illness but with predisposing risk factors.  Pregnant women;  Persons aged 65 years or older;  Patients with lung diseases, heart disease, liver disease, kidney disease, blood disorders, diabetes, neurological disorders, cancer and HIV/AIDS;  Patients on long term cortisone therapy.
  13. Warning Signals in Adults ?  Breathlessness,  chest pain,  drowsiness,  fall in blood pressure,  sputum mixed with blood,  bluish discolouration of nails;  Confusion
  14. Warning Signals in Children (Red Flag Signs) ?  Somnolence,  high and persistent fever,  inability to feed well,  convulsions,  shortness of breath,  difficulty in breathing,  Inconsolable cry, etc.
  15. Prevention and control  In order to prevent and contain outbreak of Influenza virus the following guidelines for screening, testing and isolation are to be followed:  At first all individuals seeking consultations for flu like symptoms should be screened at healthcare facilities both Government and private or examined by a doctor and these will be categorized as under:
  16. Category A  Patients with mild fever plus cough / sore throat with or without bodyache, headache, diarrhoea and vomiting will be categorized as Category-A.  They do not require Oseltamivir and should be treated for the symptoms mentioned above. The patients should be monitored for their progress and reassessed at 24 to 48 hours by the doctor.  No testing of the patient for Influenza is required.  Patients should confine themselves at home and avoid mixing up with public and high risk members in the family.
  17. Category B  (i) In addition to all the signs and symptoms mentioned under Category-A, if the patient has high grade fever and severe sore throat, may require home isolation and Oseltamivir;  (ii) In addition to all the signs and symptoms mentioned under Category-A, individuals having one or more of the following high risk conditions shall be treated with Oseltamivir:
  18. Category B  Children with mild illness but with predisposing risk factors.  Pregnant women;  Persons aged 65 years or older;  Patients with lung diseases, heart disease, liver disease, kidney disease, blood disorders, diabetes, neurological disorders, cancer and HIV/AIDS;  Patients on long term cortisone therapy
  19. Category B  No tests for Influenza is required for Category-B (i) and (ii).  All patients of Category-B (i) and (ii) should confine themselves at home and avoid mixing with public and high risk members in the family.  Broad Spectrum antibiotics as per the Guideline for Community-acquired pneumonia (CAP) may be prescribed.
  20. Category C  In addition to the above signs and symptoms of Category-A and B, if the patient has one or more of the following:  Breathlessness, chest pain, drowsiness, fall in blood pressure, sputum mixed with blood, bluish discolouration of nails;
  21. Category C  Children with influenza like illness who had a severe disease as manifested by the red flag signs (Somnolence, high and persistent fever, inability to feed well, convulsions, shortness of breath, difficulty in breathing, etc).  Worsening of underlying chronic conditions.  All these patients mentioned above in Category-C require testing, immediate hospitalization and treatment.
  22. Prevention
  23. रोकथाम के उपाय क्या करैं १. ख ांसते य छ ांकते समय अपने मांह व न क को टिश्यू य रूम ल से कवर करैं | २. अपनी आांख, न क य मांह को छू ने से पहले ह थों को अच्छ तरह स बन से धोयें | ३. बीम र व्यक्तत से दूरी बन ये रखें | ४. कोई भी तकलीफ होने पर डॉतिर की सल ह अवश्य लें | ५. खूब प नी पीयें, पोषक भोजन ख यें और भरपूर नीांद लें | क्या नह ीं करैं १.ह थ ममल ने, गले ममलने और चम्बन लेने से बचें | २. भीड़ व ले स्थ नों पर ज ने से बचें | ३. फ्लू रोगी के अधधक ननकि न ज यें | ४. जह ाँ तक हो सके अपनी आाँख, न क य मांह को न छयें | ५. अपने ह थों पर ख ांसे य छ कें नहीां ६. ड तिर की सल ह के बबन कोई दव ई न लें |
  24. Vaccine  While declaring the Pandemic to be over in August 2010, WHO conveyed that Pandemic Influenza A (HINI) virus that caused Pandemic [2009-2010] would circulate as Seasonal Influenza virus and would continue to do so for years to come.  WHO recommended vaccine only for High Risk Group  Ministry of Health and Family Welfare recommends the trivalent inactivated influenza vaccine.
  25. Vaccine  The ICMR has recommended on the following Seasonal Influenza vaccine composition, for the period 2017-2018. The recommended Trivalent vaccine should have:  an A/Michigan/45/2015 (H1N1)pdm09-like virus  an A/Hong Kong/4801/2014 (H3N2) – like virus  a B/Brisbane/60/2008-like virus
  26. Vaccine  The available vaccine takes about 2-3 weeks for development of immunity. Hence for the health care workers working in an environment with likelihood of exposure to Influenza virus, vaccine should be administered at least one month prior to the commencement of the season, till such time use of chemoprophylaxis may be considered.
  27. Vaccine  The available vaccine takes about 2-3 weeks for development of immunity. Hence for the health care workers working in an environment with likelihood of exposure to Influenza virus, vaccine should be administered at least one month prior to the commencement of the season, till such time use of chemoprophylaxis may be considered.
  28. Limitations of the Influenza Vaccination  Influenza vaccination is most effective when circulating viruses are well-matched with vaccine viruses.  Even with appropriate matching, efficacy of vaccine may be about 70% to 80%.  In case the locally circulating virus is different from vaccine virus recommended by WHO, it may be partially effective or not be effective at all.  Hence, vaccine should not give a false sense of security.
  29. High Risk Groups for whom vaccine is recommended by WHO  Health Care workers, working in hospital / institutional settings (doctors, nurses, paramedics) with likelihood of exposure to Influenza virus  Young children  Pregnant women;  Persons aged 65 years or older;  Patients with Comorbidity  Patients with compromised immunity
  30. USE OF MASKS  There are two types of masks which are recommended for various categories of personnel depending upon the work environment; 1. Triple layer surgical mask 2. N 95 Respirator  Change the mask after six hours or as soon as they become wet.  Disposable masks are never to be reused and should be disposed off.  Never touch the potentially infected outer surface of the mask while removing it.
  31. USE OF MASKS  There is no scientific evidence to show health benefit of using masks for members of public. In fact erroneous use of masks or continuous use of a disposable mask for longer than 6 hours or repeated use of same mask may actually increase risk of infection further.  In the hospital setting used masks should be disposed off in the identified infectious waste disposal bag/container.  In community settings, it may be disposed off either by burning or deep burial.
  32. Triple layer surgical mask  Suspect/ probable/confirmed cases of influenza.  The care provider in home care settings  Close family contacts of such cases undergoing home care should also use Triple layer surgical mask.  All medical personnel (Doctor, nursing and paramedical staff) would use Disposable Triple layer surgical mask while interacting with patients in screening area.  All patients, Medical and nursing staff in the isolation wards.
  33. Triple layer surgical mask  Personnel involved in handling dead bodies of suspect/confirmed cases (Mortuary)  Ambulance Staff including driver.  Doctors /Private practitioners with other health workers in screening centres / general practice  Health workers involved in community surveillance  Security personnel working in an infected/ potentially infected area for example Influenza ward in a hospital, screening centre etc.
  34. N 95 Respirator  Staff involved in any aerosol generating procedures like suction, intubation, nebulization, etc. they must use N95 Respirator  Medical personnel need to collect clinical samples from patients.  Medical personnel in ICU  Medical personnel in laboratory
  35. Tamiflu (Oseltamivir)  Oseltamivir is the recommended drug for treatment. Dose for treatment is as follows -  By Weight:  o For weight <15kg 30 mg BD for 5 days  o 15-23kg 45 mg BD for 5 days  o 24-<40kg 60 mg BD for 5 days  o >40kg 75 mg BD for 5 days
  36. Tamiflu (Oseltamivir)  For infants:  o < 3 months 12 mg BD for 5 days  o 3-5 months 20 mg BD for 5 days  o 6-11 months 25 mg BD for 5 days  It is also available as syrup (12mg per ml)
  37. Q 1. SWINE FLU IS CAUSED BY ? A. BACTERIA B. VIRUS C. (FUNGUS D. CONTAMINATED WATER
  38. Q 1. SWINE FLU IS CAUSED BY ? B. VIRUS
  39. Q 2. SWINE FLU SPREAD INCREASES IN ? A. Winters B. Summers C. Rain D. Spring
  40. Q 2. SWINE FLU SPREAD INCREASES IN ? Winters & Rainy season
  41. Q3. DRUG USED IN SWINE FLU TREATMENT? A. AMIKACIN B. TAMIFLU (OSELTAMIVIR) C. CETRIZINE D. GLICLAZIDE
  42. Q3. DRUG USED IN SWINE FLU TREATMENT ? B. TAMIFLU
  43. Q4. SYMPTOMS OF SWINE FLU ARE ? A.Fever B.Sore throat C.Cough D. Body ache E. All of the above
  44. Q4. SYMPTOMS OF SWINE FLU ARE ? E. All of the above
  45. Q5. What are the preventive measures of Swine flu ? A. Cover your cough and sneeze. B. Wash your hands at regular interval. C. Avoid touching your eye, nose and mouth unnecessarily. D. Keep safe distance from an infected individual. E. All of the above.
  46. Q5. What are the preventive measures of Swine flu ? E. All of the above
  47. TAKE HOME MESSAGE

Hinweis der Redaktion

  1. Prepared on 04 March 2015
  2. Triple Layer Surgical Mask- Tie on Mask of Non-woven, Hypoallergenic 3 ply construction with filter in between offering >99 percent standard with 4 tie strings. N-95 Respirator Mask - Filter efficiency of 95 % or more against particulate aerosols. The mask should be provided with expiration valve. It should be disposable & to be able to fit for wide range of face sizes. It should accompany with certification from NIOSH (National Institute for Occupational Safety and Health) or any other internationally accepted certification.
Anzeige